IL1B and neoplasm: This chronic inflammatory state promotes the release of cytokines (e.g., IL-1β, IL-6, IL-10, IL-18, TNF-α) and growth factors that facilitate tumor cell proliferation, invasion, and angiogenesis, while simultaneously impairing effective immune surveillance against malignant cells.